Lorenza Dall'Aglio1, Cathryn M Lewis2, Oliver Pain3. 1. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Department of Child and Adolescent Psychiatry, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands; Generation R Study Group, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. 2. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. 3. Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Electronic address: oliver.pain@kcl.ac.uk.
Abstract
BACKGROUND: Major depression (MD) is determined by a multitude of factors including genetic risk variants that regulate gene expression. We examined the genetic component of gene expression in MD by performing a transcriptome-wide association study (TWAS), inferring gene expression-trait relationships from genetic, transcriptomic, and phenotypic information. METHODS: Genes differentially expressed in depression were identified with the TWAS FUSION method, based on summary statistics from the largest genome-wide association analysis of MD (n = 135,458 cases, n = 344,901 controls) and gene expression levels from 21 tissue datasets (brain; blood; thyroid, adrenal, and pituitary glands). Follow-up analyses were performed to extensively characterize the identified associations: colocalization, conditional, and fine-mapping analyses together with TWAS-based pathway investigations. RESULTS: Transcriptome-wide significant differences between cases and controls were found at 94 genes, approximately half of which were novel. Of the 94 significant genes, 6 represented strong, colocalized, and potentially causal associations with depression. Such high-confidence associations include NEGR1, CTC-467M3.3, TMEM106B, LRFN5, ESR2, and PROX2. Lastly, TWAS-based enrichment analysis highlighted dysregulation of gene sets for, among others, neuronal and synaptic processes. CONCLUSIONS: This study sheds further light on the genetic component of gene expression in depression by characterizing the identified associations, unraveling novel risk genes, and determining which associations are congruent with a causal model. These findings can be used as a resource for prioritizing and designing subsequent functional studies of MD.
BACKGROUND:Major depression (MD) is determined by a multitude of factors including genetic risk variants that regulate gene expression. We examined the genetic component of gene expression in MD by performing a transcriptome-wide association study (TWAS), inferring gene expression-trait relationships from genetic, transcriptomic, and phenotypic information. METHODS: Genes differentially expressed in depression were identified with the TWAS FUSION method, based on summary statistics from the largest genome-wide association analysis of MD (n = 135,458 cases, n = 344,901 controls) and gene expression levels from 21 tissue datasets (brain; blood; thyroid, adrenal, and pituitary glands). Follow-up analyses were performed to extensively characterize the identified associations: colocalization, conditional, and fine-mapping analyses together with TWAS-based pathway investigations. RESULTS: Transcriptome-wide significant differences between cases and controls were found at 94 genes, approximately half of which were novel. Of the 94 significant genes, 6 represented strong, colocalized, and potentially causal associations with depression. Such high-confidence associations include NEGR1, CTC-467M3.3, TMEM106B, LRFN5, ESR2, and PROX2. Lastly, TWAS-based enrichment analysis highlighted dysregulation of gene sets for, among others, neuronal and synaptic processes. CONCLUSIONS: This study sheds further light on the genetic component of gene expression in depression by characterizing the identified associations, unraveling novel risk genes, and determining which associations are congruent with a causal model. These findings can be used as a resource for prioritizing and designing subsequent functional studies of MD.
Authors: R Jansen; B W J H Penninx; V Madar; K Xia; Y Milaneschi; J J Hottenga; A R Hammerschlag; A Beekman; N van der Wee; J H Smit; A I Brooks; J Tischfield; D Posthuma; R Schoevers; G van Grootheest; G Willemsen; E J de Geus; D I Boomsma; F A Wright; F Zou; W Sun; P F Sullivan Journal: Mol Psychiatry Date: 2015-05-26 Impact factor: 15.992
Authors: Hyo Jung Kang; Yuka Imamura Kawasawa; Feng Cheng; Ying Zhu; Xuming Xu; Mingfeng Li; André M M Sousa; Mihovil Pletikos; Kyle A Meyer; Goran Sedmak; Tobias Guennel; Yurae Shin; Matthew B Johnson; Zeljka Krsnik; Simone Mayer; Sofia Fertuzinhos; Sheila Umlauf; Steven N Lisgo; Alexander Vortmeyer; Daniel R Weinberger; Shrikant Mane; Thomas M Hyde; Anita Huttner; Mark Reimers; Joel E Kleinman; Nenad Sestan Journal: Nature Date: 2011-10-26 Impact factor: 49.962
Authors: David M Howard; Mark J Adams; Toni-Kim Clarke; Jonathan D Hafferty; Jude Gibson; Masoud Shirali; Jonathan R I Coleman; Saskia P Hagenaars; Joey Ward; Eleanor M Wigmore; Clara Alloza; Xueyi Shen; Miruna C Barbu; Eileen Y Xu; Heather C Whalley; Riccardo E Marioni; David J Porteous; Gail Davies; Ian J Deary; Gibran Hemani; Klaus Berger; Henning Teismann; Rajesh Rawal; Volker Arolt; Bernhard T Baune; Udo Dannlowski; Katharina Domschke; Chao Tian; David A Hinds; Maciej Trzaskowski; Enda M Byrne; Stephan Ripke; Daniel J Smith; Patrick F Sullivan; Naomi R Wray; Gerome Breen; Cathryn M Lewis; Andrew M McIntosh Journal: Nat Neurosci Date: 2019-02-04 Impact factor: 28.771
Authors: Alexander Gusev; Kate Lawrenson; Xianzhi Lin; Paulo C Lyra; Siddhartha Kar; Kevin C Vavra; Felipe Segato; Marcos A S Fonseca; Janet M Lee; Tanya Pejovic; Gang Liu; Beth Y Karlan; Matthew L Freedman; Houtan Noushmehr; Alvaro N Monteiro; Paul D P Pharoah; Bogdan Pasaniuc; Simon A Gayther Journal: Nat Genet Date: 2019-05-01 Impact factor: 38.330
Authors: Calwing Liao; Alexandre D Laporte; Dan Spiegelman; Fulya Akçimen; Ridha Joober; Patrick A Dion; Guy A Rouleau Journal: Nat Commun Date: 2019-10-01 Impact factor: 14.919
Authors: Oliver Pain; Andrew J Pocklington; Peter A Holmans; Nicholas J Bray; Heath E O'Brien; Lynsey S Hall; Antonio F Pardiñas; Michael C O'Donovan; Michael J Owen; Richard Anney Journal: Biol Psychiatry Date: 2019-05-11 Impact factor: 13.382
Authors: Rachel L Kember; Henry R Kranzler; Sylvanus Toikumo; Heng Xu; Joel Gelernter Journal: Neuropsychopharmacology Date: 2022-08-08 Impact factor: 8.294
Authors: Amy E Miles; Fernanda C Dos Santos; Enda M Byrne; Miguel E Renteria; Andrew M McIntosh; Mark J Adams; Giorgio Pistis; Enrique Castelao; Martin Preisig; Bernhard T Baune; K Oliver Schubert; Cathryn M Lewis; Lisa A Jones; Ian Jones; Rudolf Uher; Jordan W Smoller; Roy H Perlis; Douglas F Levinson; James B Potash; Myrna M Weissman; Jianxin Shi; Glyn Lewis; Brenda W J H Penninx; Dorret I Boomsma; Steven P Hamilton; Etienne Sibille; Ahmad R Hariri; Yuliya S Nikolova Journal: Neuropsychopharmacology Date: 2021-09-29 Impact factor: 7.853
Authors: Joshua W Buckholtz; Jordan W Smoller; Maria Dalby; Morana Vitezic; Niels Plath; Lene Hammer-Helmich; Yunxuan Jiang; Chao Tian; Devika Dhamija; Catherine H Wilson; David Hinds; Patrick F Sullivan Journal: Transl Psychiatry Date: 2022-03-25 Impact factor: 7.989
Authors: Jennifer Monereo-Sánchez; Miranda T Schram; Oleksandr Frei; Kevin O'Connell; Alexey A Shadrin; Olav B Smeland; Lars T Westlye; Ole A Andreassen; Tobias Kaufmann; David E J Linden; Dennis van der Meer Journal: Front Neurosci Date: 2021-07-05 Impact factor: 4.677